Skip to content

Tectonic Therapeutics TECX Deferred Offering Costs Included In Accrued Expenses And Other Liabilities

Deferred Offering Costs Included In Accrued Expenses And Other Liabilities at other companies

KRAKacquisition
 logo
KRAKacquisition KRAQ
$328.39K
CEP
Cantor Equity Partners II, Inc. Class A Ordinary ShareCEPT
$19.56K+2.9%
ALO
Aldabra 4 Liquidity Opportunity Vehicle ALOV
$163.78K
Montana Technologies Corporation logo
Montana Technologies CorporationAIRJ
$0-100%
NetSTREIT logo
NetSTREITNTST
$502K+1,992%
VHC
Vine Hill Capital Investment Corp. II VHCP
$43K

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept tecx:DeferredOfferingCostsIncludedInAccruedExpensesAndOtherLiabilities.

The official record: Tectonic Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's deferred offering costs included in accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's deferred offering costs included in accrued expenses and other liabilities?
Tectonic Therapeutics (TECX) reported deferred offering costs included in accrued expenses and other liabilities of $8.75K in Q4 2025.
What does deferred offering costs included in accrued expenses and other liabilities mean?
Represents the portion of costs related to upcoming or completed financing offerings that have been recognized as liabilities but not yet paid in cash. This metric provides visibility into outstanding financial obligations tied to capital-raising efforts. It is essential for understanding the company's short-term liabilities and upcoming cash requirements for financing-related expenses.